Charles Dunn

Principal, Therapeutics atSV Health InvestorsMassachusetts

Charles Dunn is a Principal at SV Health Investors, focusing on biotech. He helps form and fund companies developing transformational medicines, such as Draig Therapeutics.

What Charles can write

Writes checks ofNot reported
Comes in atPre-seed, Seed, Series A, Series BCan lead the round
Ownership target7-10%At first check
Pitch pageSubmit on their siteThe firm asks founders to apply here.

Investments named in public bios

Draig Therapeutics

Focus

biotechneuropsychiatric disorders

Also at SV Health Investors

Partners like Charles

At firms with a similar stage, sector and check size.

Alert me when SV Health Investors is active

One email when Charles's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Charles Dunn?

Charles Dunn is a Principal at SV Health Investors, focusing on biotech. He helps form and fund companies developing transformational medicines, such as Draig Therapeutics.

How much does Charles Dunn invest?

SV Health Investors has not reported a check size. It invests at pre-seed, seed, series a, series b.

How do I pitch Charles Dunn?

A warm intro from a founder SV Health Investors backed works best.

Last updated 2026-10-15. Is this you? Ask for a correction.